In Patients with Advanced Urothelial Carcinoma, Immune Checkpoint Inhibition Prior to Enfortumab Vedotin Is Associated with High-grade Skin Toxicity.

Molina, Gabriel E; Schwartz, Ben; Srinivas, Sandy; Shah, Sumit; Zaba, Lisa C

Molina, Gabriel E; Schwartz, Ben; Srinivas, Sandy; Shah, Sumit; Zaba, Lisa C.

Afiliação

Molina GE; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.
Schwartz B; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.
Srinivas S; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Shah S; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Zaba LC; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: lisa.zaba@stanford.edu.

Eur Urol ; 83(4): 377-378, 2023 04.

Article em En | MEDLINE | ID: mdl-36623949

Assuntos

Carcinoma de Células de Transição; Neoplasias da Bexiga Urinária; Humanos; Inibidores de Checkpoint Imunológico; Anticorpos Monoclonais

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google